NCT02695004View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Alzheimer's Disease
Interventions
DRUG

DKF-310

DRUG

Placebo

Trial Locations (1)

Unknown

Seoul National Univ. Bundang Hospital, Seongnam

Sponsors
All Listed Sponsors
lead

Dongkook Pharmaceutical Co., Ltd.

INDUSTRY